These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 21880181)

  • 1. Epithelial-mesenchymal transition in breast cancer progression and metastasis.
    Wang Y; Zhou BP
    Chin J Cancer; 2011 Sep; 30(9):603-11. PubMed ID: 21880181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A "NOTCH" Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer.
    Kar R; Jha NK; Jha SK; Sharma A; Dholpuria S; Asthana N; Chaurasiya K; Singh VK; Burgee S; Nand P
    Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31766724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
    Cao H; Xu E; Liu H; Wan L; Lai M
    Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition.
    Takebe N; Warren RQ; Ivy SP
    Breast Cancer Res; 2011 Jun; 13(3):211. PubMed ID: 21672282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-mesenchymal transition, cancer stem cells and treatment resistance.
    Dave B; Mittal V; Tan NM; Chang JC
    Breast Cancer Res; 2012 Jan; 14(1):202. PubMed ID: 22264257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression.
    Ingthorsson S; Briem E; Bergthorsson JT; Gudjonsson T
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):139-148. PubMed ID: 27815674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
    Foroni C; Broggini M; Generali D; Damia G
    Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
    Jin W
    Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
    Micalizzi DS; Farabaugh SM; Ford HL
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.
    Zu X; Zhang Q; Cao R; Liu J; Zhong J; Wen G; Cao D
    Cell Tissue Res; 2012 Jan; 347(1):73-84. PubMed ID: 21845401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
    Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
    Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug Resistance.
    Du F; Liu H; Lu Y; Zhao X; Fan D
    Crit Rev Oncog; 2017; 22(3-4):275-282. PubMed ID: 29604904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
    Mallini P; Lennard T; Kirby J; Meeson A
    Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
    Lu W; Kang Y
    Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
    Latorre E; Carelli S; Raimondi I; D'Agostino V; Castiglioni I; Zucal C; Moro G; Luciani A; Ghilardi G; Monti E; Inga A; Di Giulio AM; Gorio A; Provenzani A
    Cancer Res; 2016 May; 76(9):2626-36. PubMed ID: 27197265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.